K. Matsumoto et al. / Tetrahedron 67 (2011) 6474e6478
6477
21
5); [
1574, 1505, 1462, 1418, 1373, 1213, 1136, 1105, 1069, 1030, 928, 835,
768, 729, 696 cmꢁ1 1H NMR (CDCl3):
a
]
ꢁ28.1 (c 2.06, CHCl3); FTIR (KBr): 2910, 2845, 1711, 1609,
[
a
]
21 þ18.0 (c 1.02, CHCl3); FTIR (neat): 3028, 2924,1755,1497,1454,
D
D
1416, 1352, 1134, 1078, 897, 872, 754, 698, 567 cmꢁ1
;
1H NMR
;
d
7.87 (d, J¼8.3 Hz, 1H),
(CDCl3): d 7.35e7.32 (m, 5H), 7.27e7.23 (m, 2H), 7.19e7.16 (m, 1H),
6.52e6.48 (m, 2H), 5.76 (d, J¼2.4 Hz, 1H), 3.89 (s, 3H), 2.86 (s, 3H),
7.08e7.06 (m, 2H), 5.73 (d, J¼2.4 Hz,1H), 4.04 (d, J¼2.4 Hz,1H), 2.80
3.06 (ddd, J¼2.4, 5.9, 6.3 Hz, 1H), 1.85e1.70 (m, 2H), 1.61e1.26 (m,
(t, J¼7.81 Hz, 2H), 2.61e2.47 (m, 2H) ppm; 13C NMR (CDCl3):
d 172.3,
8H), 0.88 (t, J¼6.8, 3H) ppm; 13C NMR (CDCl3):
d
165.0, 164.9, 162.1,
139.8, 132.4, 128.5, 128.4, 128.1, 128.0, 127.2, 126.3, 76.8, 57.2, 35.5,
30.3 ppm; elemental analysis: calcd (%) for C17H16O3: C 76.10, H
6.01; found: C 76.20, H 5.92.
134.3, 110.9, 104.7, 98.9, 76.1, 56.8, 55.9, 55.5, 31.7, 29.1, 27.1, 26.0,
22.5, 14.0 ppm; elemental analysis: calcd (%) for C17H24O5: C 66.21,
H 7.84; found: C 66.25, H 7.64.
4.2.12. 6-Oxabicyclo[3.1.0]hexan-1-yl benzoate (15). Colorless oil;
21%, 85% ee (DAICEL CHIRALPAK AD-H, n-hexane/i-PrOH 99:1);
4.2.6. cis-3-Hexyloxiran-2-yl 3-phenylpropanoate (7). Colorless oil;
20 ꢁ29.5 (c 0.66, CHCl3) [lit.5c
[a]
25 ꢁ26.8 (c 0.41, CHCl3), 80% ee];
20
[a]
D
D
37 mg, 27%; 63% ee (CHIRALPAK IC, n-hexane/i-PrOH 90/10); [a]
D
FTIR (neat): 2937, 2855,1730,1601,1421,1275,1252,1202,1067,1024,
ꢁ13.1 (c 0.62, CHCl3); FTIR (neat): 2910, 2856, 1757, 1497, 1454,
1358, 1136, 1109, 750, 700 cmꢁ1 1H NMR (CDCl3):
7.31e7.19 (m,
941, 903, 708 cmꢁ1; 1H NMR (400 MHz, CDCl3):
d 8.06e8.04 (m, 2H),
;
d
7.61e7.57 (m, 1H), 7.47e7.43 (m, 2H), 3.80 (s, 1H), 2.46 (dd, J¼8.8,
5H), 5.55 (d, J¼2.4, 1H), 2.99e2.95 (m, 3H), 2.73e2.69 (m, 2H),
1.68e1.24 (m, 10H), 0.89 (t, J¼6.3 Hz, 3H) ppm; 13C NMR (CDCl3):
13.2 Hz,1H), 2.18e2.10 (m,1H), 2.01e1.88 (m, 2H),1.81e1.73 (m,1H),
1.62e1.52 ppm (m, 1H); 13C NMR (100 MHz, CDCl3):
d 165.0, 133.6,
d
172.6, 140.0, 128.5, 128.2, 126.4, 76.1, 56.6, 35.7, 31.6, 30.5, 29.0,
129.9, 129.2, 128.5, 89.8, 62.6, 28.2, 26.0, 20.0 ppm; elemental anal-
ysis: calcd (%) for C12H12O3:C 70.57, H 5.92; found: C 70.51, H 6.00.
26.8, 25.9, 22.5, 14.0 ppm; elemental analysis: calcd (%) for;
C17H24O3: C 73.88, H 8.75; found: C 74.04, H 8.78.
4.3. Reduction of epoxide 4
4.2.7. cis-3-Isobutyloxiran-2-yl 4-methoxybenzoate (8). Colorless
oil; 107 mg, 86%, 98% ee (DAICEL CHIRALPAK IC, hexane/i-PrOH
20
To a solution of epoxide 4 (100.0 mg) in diethyl ether (3.0 mL)
was added lithium borohydride (23.5 mg) at 0 ꢀC and the resulting
mixture was stirred at room temperature. After 30 min, the reaction
was quenched with saturated NH4Cl aq. The reaction mixture was
extracted with ether, and the extracts were washed with water and
brine and then dried over anhydrous Na2SO4. The crude product
was purified by column chromatography on basic silica gel (n-
hexane/ether¼4:1) to give the 1,2-diol 13 (48.9 mg, 93%). To a so-
lution of diol 13 (30.0 mg) in CH2Cl2 (1.0 mL) was added triethyl-
80:20); [
a
]
ꢁ28.6 (c 2.43, CHCl3); FTIR (neat): 2957, 1730, 1605,
D
1512, 1466, 1317, 1261, 1165, 1142, 1099, 1024, 843, 770 cmꢁ1
;
1H
NMR (400 MHz, CDCl3): 8.01e7.97 (m, 2H), 6.96e6.92 (m, 2H),
d
5.77 (d, J¼2.4, 1H), 3.87 (s, 3H), 3.14e3.10 (m, 1H), 1.96e1.86 (m,
1H), 1.75e1.61 (m, 2H), 1.03 (d, J¼6.8 Hz, 3H), 1.02 ppm (d, J¼6.8 Hz,
3H); 13C NMR (100 MHz, CDCl3):
d 165.8, 163.9, 131.9, 121.4, 113.8,
76.1, 55.7, 55.4, 35.7, 26.3, 22.8, 22.4 ppm; elemental analysis: calcd
(%) for C14H18O4:C 67.18, H 7.25; found: C 67.13, H 7.25.
amine (85.4
mL) and benzoylchloride (72.6 mL). After stirring
4.2.8. cis-3-Cyclohexyloxiran-2-yl 4-methoxybenzoate (9). Colorless
oil; 123 mg, 89%; 98% ee (CHIRALPAK IC, n-hexane/i-PrOH 80/20);
overnight, the reaction was quenched with saturated NaHCO3 aq.
The reaction mixture was extracted with CH2Cl2, and the extracts
were washed with brine and then dried over anhydrous Na2SO4.
The crude product was purified by column chromatography on
basic silica gel (n-hexane/ether¼20:1) to give the dibenzoate 14
(66.2 mg, 91%); 92% ee (CHIRALPAK AD-H, n-hexane/i-PrOH 99/1);
[
a]
20 ꢁ31.5 (c 1.60, CHCl3); FTIR (neat): 2910, 2857, 1726, 1607, 1582,
D
1512, 1450, 1421, 1252, 1169, 1094, 1028, 970, 879, 831, 799, 768,
696, 613, 554, 509 cmꢁ1 1H NMR (CDCl3):
; d 7.99e7.96 (m, 2H),
6.96e6.92 (m, 2H), 5.78 (d, J¼2.4 Hz, 1H), 3.87 (s, 3H), 2.81 (dd,
J¼2.4, 8.8 Hz, 1H), 2.03e2.01 (m, 1H), 1.77e1.55 (m, 5H), 1.36e1.11
[
a
]
25 þ4.97 (c 0.71, CHCl3) [lit.17
[
a
]
D
24 þ5.4 (c 0.63, CHCl3), >99% ee];
(m, 5H) ppm; 13C NMR (CDCl3):
d 166.2, 164.3, 132.2, 121.7, 114.1,
D
FTIR (neat): 2920, 2851, 1715, 1684, 1649, 1583, 1458, 1261, 1177,
76.7, 60.9, 55.8, 36.5, 30.6, 28.9, 26.5, 25.8, 25.6 ppm; elemental
analysis: calcd (%) for C16H20O4: C 69.54, H 7.30; found: C 69.80,
H 7.28.
1069, 1026, 849, 716, 689 cmꢁ1 1H NMR (CDCl3):
; d 8.06e8.00 (m,
4H), 7.57e7.52 (m, 2H), 7.45e7.39 (m, 4H), 5.53e5.47 (m, 1H), 4.56
(dd, J¼3.4, 11.7 Hz, 1H), 4.47 (dd, J¼6.3, 11.7 Hz, 1H), 1.89e1.74 (m,
2H), 1.52e1.26 (m, 8H), 0.87 (t, J¼6.8 Hz, 3H) ppm; 13C NMR
4.2.9. cis-3-tert-Butyloxiran-2-yl 4-methoxybenzoate (10). Colorless
oil; 113 mg, 90%; >99% ee (CHIRALPAK IC, n-hexane/i-PrOH 80/20);
(CDCl3):
d 166.3, 166.1, 133.0, 133.0, 130.2, 129.9, 129.7, 128.4, 72.2,
65.7, 31.6, 31.0, 29.1, 25.1, 22.5, 14.0 ppm; elemental analysis: calcd
(%) for C22H26O4: C 74.55, H 7.39; found: C 74.48, H 7.32.
[
a
]
19 ꢁ26.3 (c 1.89, CHCl3); FTIR (neat): 2950, 1728, 1607, 1582, 1512,
D
1421, 1367, 1256, 1090, 1007, 959, 930, 847, 806, 768, 696, 617,
554 cmꢁ1
2H), 5.72 (d, J¼2.4 Hz, 1H), 3.87 (s, 3H), 2.81 (d, J¼2.4, 1H), 1.13 (s,
9H) ppm; 13C NMR (CDCl3):
165.9, 164.0, 131.9, 121.4, 113.9, 77.6,
; d 8.00e7.96 (m, 2H), 6.96e6.92 (m,
1H NMR (CDCl3):
Acknowledgements
d
We are grateful to Nissan Chemical Industries and the Global
COE program ‘Science for Future Molecular Systems’ from MEXT
(Japan) for generous financial support. T.O. is grateful for JSPS Re-
search Fellowship for Young Scientists.
64.0, 55.5, 31.2, 27.3 ppm; elemental analysis: calcd (%) for
C14H18O4: C 67.18, H 7.25; found: C 67.19, H 7.23.
4.2.10. cis-3-Phenyloxiran-2-yl benzoate (11). Colorless oil; 100 mg,
83%; 86% ee (CHIRALPAK IC, n-hexane/i-PrOH 95/5); [
a
]
21 þ42.5 (c
D
References and notes
1.15, CHCl3); FTIR (neat): 2924, 2852, 1734, 1601, 1495, 1454, 1360,
1315, 1252, 1205, 1177, 1094, 1069, 1026, 904, 862, 756, 710, 583,
1. (a) Matsumoto, K.; Katsuki, T. In Catalytic Asymmetric Synthesis, 3rd ed.; Ojima, I.,
Ed.; John Wiley: New Jersey, 2010; pp 849e869; (b) Berkessel, A.; Groger, H.
521 cmꢁ1; 1H NMR (CDCl3):
d 7.86e7.84 (m, 2H), 7.56e7.32 (m, 8H),
€
6.01 (d, J¼2.4 Hz, 1H), 4.16 (d, J¼2.4 Hz, 1H) ppm; 13C NMR (CDCl3):
Asymmetric Organocatalysis; Wiley-VCH: Weinheim, 2005; (c) Katsuki, T. In
Comprehensive Coordination Chemistry II; McCleverty, J., Ed.; Elsevier: Oxford,
2004; Vol. 9, pp 207e227; (d) Katsuki, T. In Catalytic Asymmetric Synthesis, 2nd
ed.; Ojima, I., Ed.; Wiley-VCH: New York, NY, 2000; pp 287e316; (e) Jacobsen,
E. N.; Wu, M. H. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A.,
Yamamoto, H., Eds.; Springer: Berlin, 1999; Vol. II, pp 649e677.
d
165.9, 133.7, 132.5, 129.8, 128.7, 128.5, 128.5, 128.1, 127.3, 77.0,
57.3 ppm; elemental analysis: calcd (%) for C15H12O3: C 74.99, H
5.03; found: C 75.17, H 5.04.
2. (a) De Faveri, G.; Ilyashenko, G.; Watkinson, M. Chem. Soc. Rev. 2011, 40,
1722e1760; (b) Wong, O. A.; Shi, Y. Chem. Rev. 2008, 108, 3958e3987; (c) Xia,
Q.-H.; Ge, H.-Q.; Ye, C.-P.; Liu, Z.-M.; Su, K. X. Chem. Rev. 2005, 105, 1603e1662.
4.2.11. cis-3-Phenyloxiran-2-yl 3-phenylpropanoate (12). Colorless
oil; 105 mg, 78%; 97% ee (CHIRALPAK IC, n-hexane/i-PrOH 95/5);